☆ 4.7 Review

Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India

LANCET INFECTIOUS DISEASES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Letter Respiratory System

High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)

Sahajal Dhooria et al.

EUROPEAN RESPIRATORY JOURNAL (2022)

添加到收藏夹

Letter Virology

Follow-up CT of reversed halo sign in SARS-CoV-2 delta VOC pneumonia: A report of two cases

Jing Wu et al.

Summary: The COVID-19 outbreak in December 2019 caused global harm and urgent research is needed to understand the disease better. This study reported cases of RHS in COVID-19 patients to speculate on the pathological mechanism and predict the prognosis of the disease through multiple CT follow-up comparisons.

JOURNAL OF MEDICAL VIROLOGY (2022)

添加到收藏夹

Review Mycology

Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature

Himanshu Pruthi et al.

Summary: Literature on COVID-19-associated pulmonary mucormycosis (CAPM) is limited, with pulmonary artery pseudoaneurysm (PAP) being a rare complication of the disease. This study reports five cases of CAPM with PAP, showcasing the importance of early diagnosis and multimodality management in improving outcomes for these patients, who face a high mortality rate.

MYCOPATHOLOGIA (2022)

添加到收藏夹

Article Dermatology

Serum iron indices in COVID-19-associated mucormycosis: A case-control study

Mohan H. Kumar et al.

Summary: This study compared the serum iron indices in COVID-19 patients with and without COVID-19-associated mucormycosis (CAM), finding that CAM cases had lower TIBC levels than COVID-19 controls, suggesting a potential association with dysregulated iron metabolism in the pathogenesis of CAM.

MYCOSES (2022)

添加到收藏夹

Article Dermatology

Results from a national survey on COVID-19-associated mucormycosis in Germany: 13 patients from six tertiary hospitals

Danila Seidel et al.

Summary: COVID-19-associated mucormycosis is rare in Germany, mostly reported in patients with comorbidities and impaired immune system who have severe COVID-19 and are treated in the ICU, with a high mortality rate. Compared to mainly rhino-orbito-cerebral CAM in patients with mild COVID-19 in India, the risk for CAM is higher in hospitalized COVID-19 patients.

MYCOSES (2022)

添加到收藏夹

Article Dermatology

COVID-19-associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico

Salvador Guzman-Castro et al.

Summary: This study described six cases of COVID-19-associated mucormycosis in a single center in Western Mexico, with most patients having diabetes and all receiving corticosteroid therapy. It was found that in this region, CAM was 300 times more frequent among COVID individuals than the estimates for the general population. Identifying individuals at risk and avoiding unnecessary corticosteroid use in non-severe COVID-19 cases could help prevent this complicated fungal infection.

MYCOSES (2022)

添加到收藏夹

Article Critical Care Medicine

Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study

Jean-Pierre Gangneux et al.

Summary: This study demonstrates a high prevalence of invasive pulmonary aspergillosis and candidemia in mechanically ventilated patients with severe COVID-19, and a high mortality associated with pr/pb CAPA. These findings highlight the importance of active surveillance for fungal pathogens in patients with severe COVID-19.

LANCET RESPIRATORY MEDICINE (2022)

添加到收藏夹

Review Infectious Diseases

The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries

Martin Hoenigl et al.

Summary: Reports of COVID-19-associated mucormycosis, particularly among patients with uncontrolled diabetes, have been increasing since early 2021. Most patients with COVID-19-associated mucormycosis have uncontrolled diabetes and receive systemic corticosteroid treatment, and rhino-orbital cerebral mucormycosis is the most common disease. COVID-19-associated mucormycosis is associated with high mortality and a significant proportion of survivors experience life-changing morbidities.

LANCET MICROBE (2022)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

CT Findings of COVID-19-associated Pulmonary Mucormycosis: A Case Series and Literature Review

Mandeep Garg et al.

RADIOLOGY (2022)

添加到收藏夹

Letter Respiratory System

The Reversed Halo Sign and la COVID-19: Possible Histopathological Mechanisms Related to the Appearance of This Imaging Finding

Anderson Ribeiro de Sales et al.

ARCHIVOS DE BRONCONEUMOLOGIA (2021)

添加到收藏夹

Letter Critical Care Medicine

Safety and Efficacy of Bronchoscopy in Critically Ill Patients With Coronavirus Disease 2019

Stephanie H. Chang et al.

CHEST (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Absence of Case of Mucormycosis (March 2020-May 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit

Bindu Mulakavalupil et al.

Summary: Strict adherence to protocol of low dose steroids and strict glycemic control helped in reducing or eliminating the risk and incidence of mucormycosis in a tertiary care dedicated covid-19 hospital.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Diabetes mellitus and Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): A wake-up call from Egypt

Mostafa Alfishawy et al.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Pulmonary aspergillosis and mucormycosis in a patient with COVID-19

Andre K. Johnson et al.

Summary: Invasive pulmonary mucormycosis and aspergillosis are rare and life-threatening fungal infections, often seen in patients with diabetes, neutropenia, or corticosteroid use. These infections are recognized as secondary complications of COVID-19, particularly in critically ill patients. This report presents the first case of combined probable pulmonary aspergillosis and possible mucormycosis in a male with COVID-19 in the ICU.

MEDICAL MYCOLOGY CASE REPORTS (2021)

添加到收藏夹

Article Dermatology

Bronchoscopy safety precautions for diagnosing COVID-19 associated pulmonary aspergillosis-A simulation study

Philipp Koehler et al.

Summary: Through simulation experiments, it was found that there is extensive aerosol generation, droplet spread, and surface contamination during bronchoscopy. By repurposing covers for ultrasound transducers or endoscopic cameras to seal the tube opening during bronchoscopy in mechanically ventilated patients, exposure of health-care workers and surface contamination can be efficiently reduced.

MYCOSES (2021)

添加到收藏夹

Review Infectious Diseases

Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis

Valliappan Muthu et al.

Summary: The study aimed to assess the mortality and trend of pulmonary mucormycosis (PM) in immunocompromised patients. Results showed that mortality of PM has improved over time, with combined medical-surgical therapy associated with lower mortality risk than medical treatment alone. Risk of death was higher in disseminated disease compared to isolated PM, while diabetes mellitus was not associated with higher mortality risk.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Microbiology

Molecular identification of pathogenic fungi in formalin- fixed and paraffin-embedded tissues

Joseph Jillwin et al.

Summary: This study developed a new protocol for fungal identification from formalin-fixed and paraffin-embedded (FFPE) tissues, using DNA extraction from 63 FFPE tissues with histopathologically confirmed invasive fungal infections (IFIs). The results showed that DNA yield was significantly higher with conventional PCI method compared to commercial kit, and PCR targeting ITS1 region had the best test accuracy among the different rDNA regions tested.

JOURNAL OF MEDICAL MICROBIOLOGY (2021)

添加到收藏夹

Article Immunology

Guidance on Imaging for Invasive Pulmonary Aspergillosis and Mucormycosis: From the Imaging Working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC/MSGERC

Barbara D. Alexander et al.

Summary: Clinical imaging plays a crucial role in early detection and diagnosis of invasive fungal diseases (IFD). Volumetric high-resolution computed tomography (CT) is the preferred method for lung imaging, providing valuable diagnostic information. Certain radiologic patterns, such as the halo sign and reversed halo sign, can help differentiate between invasive pulmonary aspergillosis and pulmonary mucormycosis.

CLINICAL INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Respiratory System

Is high-dose glucocorticoid beneficial in COVID-19?

Valliappan Muthu et al.

EUROPEAN RESPIRATORY JOURNAL (2021)

添加到收藏夹

Article Dermatology

COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series

Eelco F. J. Meijer et al.

Summary: CAPA has emerged as an invasive fungal disease affecting previously immunocompetent, mechanically ventilated ICU patients with high mortality. This study found a significant decrease in the number of COVID-19 patients needing mechanical ventilation in the ICU during the second wave, but a slightly higher percentage were diagnosed with CAPA. The use of dexamethasone did not show significant impact on CAPA incidence or mortality rates.

MYCOSES (2021)

添加到收藏夹

Article Microbiology

Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy

Christoph Zurl et al.

Summary: Viral infections can lead to ARDS and increase the risk of secondary pulmonary infections. Several studies have reported cases of severe COVID-19 complicated by secondary pulmonary aspergillosis.

JOURNAL OF FUNGI (2021)

添加到收藏夹

Review Microbiology

Global Prevalence of COVID-19-Associated Mucormycosis (CAM): Living Systematic Review and Meta-Analysis

Salman Hussain et al.

Summary: The study found a high pooled prevalence of mucormycosis among COVID-19 patients, with seven cases per 1000 patients, and a high mortality rate among CAM patients, indicating the need for appropriate treatment strategies.

JOURNAL OF FUNGI (2021)

添加到收藏夹

Article Microbiology

COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors

Abanoub Riad et al.

Summary: The majority of patients with COVID-19-associated mucormycosis (CAM) were male with comorbidities like diabetes and cardiovascular disease. Observational studies indicated that diabetes, steroids, and Remdesivir were not linked to increased mortality, while active screening, lung involvement, and using antifungal medications reduced mortality risk. The use of liposomal amphotericin B (LAmB) was effective in treating CAM patients with positive outcomes.

JOURNAL OF FUNGI (2021)

添加到收藏夹

Article Dermatology

Role of flexible bronchoscopy in the diagnosis of invasive fungal infections

Valliappan Muthu et al.

Summary: Flexible bronchoscopy is a safe and effective method for diagnosing invasive mould infections, with a higher success rate of diagnosis in patients with endobronchial abnormalities.

MYCOSES (2021)

添加到收藏夹

Article Microbiology

In Vitro Antifungal Drug Resistance Profiles of Clinically Relevant Members of the Mucorales (Mucoromycota) Especially with the Newer Triazoles

Andrew M. Borman et al.

Summary: Mucormycoses are highly destructive infections caused by Mucorales, with liposomal amphotericin B and surgery recommended as first line therapy. Antifungal susceptibility testing plays a crucial role in determining optimal treatment, as different species within Mucorales exhibit varying responses to antifungal drugs.

JOURNAL OF FUNGI (2021)

添加到收藏夹

Review Microbiology

Aspergillus terreus Species Complex

Cornelia Lass-Florl et al.

Summary: Infections due to Aspergillus species, particularly the Aspergillus terreus species complex, pose a significant threat to human health due to their resistance to amphotericin B and unique immune interactions. The incidence of A. terreus is increasing, leading to an expanding clinical spectrum and affecting new groups of at-risk patients. Understanding the microbiology, epidemiology, and pathogenesis of A. terreus is crucial for clinicians and researchers to address the challenges posed by this opportunistic pathogen.

CLINICAL MICROBIOLOGY REVIEWS (2021)

添加到收藏夹

Article Critical Care Medicine

Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis

Paul E. Verweij et al.

Summary: Invasive pulmonary aspergillosis (IPA) is increasingly reported in severe COVID-19 patients admitted to the ICU. The diagnosis and management of COVID-19 associated pulmonary aspergillosis (CAPA) are challenging, with bronchoscopy and bronchoalveolar lavage as key diagnostic tools. Treatment includes antifungal therapy tailored to the individual patient's clinical condition.

INTENSIVE CARE MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Relationship between chest computed tomography findings and clinical conditions of coronavirus disease (COVID-19): A multicentre experience

Nilgun Yilmaz Demirci et al.

Summary: This study investigated the clinical and chest CT features associated with clinical parameters for COVID-19 in Ankara, Turkey. Non-severe and severe cases were enrolled, with severe patients being older and having more comorbidities, higher respiratory rates, and increased inflammatory markers. Severe patients also had distinct CT findings compared to non-severe patients, with factors like consolidation and bilateral involvement predicting severe COVID-19.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

添加到收藏夹

Article Ophthalmology

Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations

Nurettin Bayram et al.

Summary: This study investigated the clinical manifestations of rhino-orbital mucormycosis (ROM) co-infection in severe COVID-19 patients, revealing a high mortality rate possibly due to immune dysregulation and the use of steroids. Physicians should be aware of the possibility of this infection in patients with COVID-19. A multidisciplinary approach can help reduce mortality.

JAPANESE JOURNAL OF OPHTHALMOLOGY (2021)

添加到收藏夹

Article Microbiology

Epidemiology and Antifungal Susceptibilities of Mucoralean Fungi in Clinical Samples from the United States

Hamid Badali et al.

Summary: This study evaluated the epidemiology and susceptibility profiles of Mucorales isolates in the United States, finding Rhizopus as the predominant genus, the respiratory tract as the main source of isolates, and amphotericin B and posaconazole as the most active antifungal drugs, with isavuconazole showing the greatest variability.

JOURNAL OF CLINICAL MICROBIOLOGY (2021)

添加到收藏夹

Review Mycology

Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World

Valliappan Muthu et al.

Summary: The COVID-19 pandemic has led to a concerning resurgence of mucormycosis, with a high number of cases reported from India. Diabetes mellitus was the most common underlying risk factor for COVID-19-associated mucormycosis in India, where the fatality rate of reported cases was relatively lower compared to globally reported cases.

MYCOPATHOLOGIA (2021)

添加到收藏夹

Article Dermatology

Mucormycosis and COVID-19: An epidemic within a pandemic in India

Lav Selarka et al.

Summary: The study found that mucormycosis can occur in COVID-19 patients, especially with factors such as diabetes, lack of vaccination, use of corticosteroids and broad-spectrum antibiotics, and the need for invasive ventilation. Timely diagnosis and appropriate treatment are crucial for high-risk populations.

MYCOSES (2021)

添加到收藏夹

Article Dermatology

Is there an association between zinc and COVID-19-associated mucormycosis? Results of an experimental and clinical study

Valliappan Muthu et al.

Summary: An increase in growth was observed in Rhizopus arrhizus isolates in zinc-enriched media, but the study did not conclusively support the hypothesis that zinc supplementation contributed to the pathogenesis of mucormycosis. More data, both in vitro and in vivo, may help clarify the role of zinc in the pathogenesis of CAM.

MYCOSES (2021)

添加到收藏夹

Article Dermatology

ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries

Shivaprakash M. Rudramurthy et al.

Summary: Globally, the incidence of COVID-19-associated mucormycosis (CAM) is rising, with a significant surge in India. The need to address misconceptions in managing and treating this infection is crucial, with a focus on early suspicion, diagnosis confirmation, glycemic control, surgical debridement, and antifungal therapy. Limited availability of amphotericin B formulations during the epidemic has led to discussions on alternative antifungal therapies.

MYCOSES (2021)

添加到收藏夹

Article Medicine, General & Internal

COVID-19-associated mucormycosis presenting to the Emergency Department-an observational study of 70 patients

A. Ramaswami et al.

Summary: A large surge in COVID-19-associated mucormycosis is occurring in India, with a retrospective study including 70 patients showing that diabetes mellitus and steroid use for COVID-19 were the most common risk factors.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2021)

添加到收藏夹

Letter Public, Environmental & Occupational Health

Cavity in pulmonary mucormycosis: Is it rare?

Valliappan Muthu et al.

TROPICAL DOCTOR (2021)

添加到收藏夹

Article Respiratory System

Outcomes of early anti-fungal therapy with aggressive surgical resection in pulmonary mucormycosis

Mohan Venkatesh Pulle et al.

Summary: This study reports on the clinical experience of managing pulmonary mucormycosis (PM) patients and proposes a management algorithm. Most patients were males with chronic kidney disease as the common predisposing factor. Aggressive surgical resection after antifungal therapy initiation significantly improved survival outcomes, with patients in the surgical group having better prognosis than those in the nonsurgical group.

LUNG INDIA (2021)

添加到收藏夹

Article Immunology

Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India

Atul Patel et al.

Summary: This study found an increase in mucormycosis cases in India during the COVID-19 pandemic, mainly due to inappropriate glucocorticoid use, resulting in a higher mortality rate among mucormycosis patients.

EMERGING INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Environmental Sciences

COVID-19-Associated Mucormycosis (CAM): An Updated Evidence Mapping

Salman Hussain et al.

Summary: This study found a high incidence of CAM with a high mortality rate among COVID-19 patients. The most common symptoms observed in CAM patients include facial pain, ptosis, and proptosis. Patients who underwent both medical and surgical management had a higher survival rate.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

添加到收藏夹

Article Immunology

COVID-19-Associated Mold Infection in Critically Ill Patients, Chile

Ricardo Rabagliati et al.

Summary: In an academic hospital in Santiago, Chile, 11% of nonimmunocompromised severe COVID-19 patients developed COVID-19-associated invasive mold infection (CAIMI), with a mortality rate of 31.2%.

EMERGING INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Mycology

Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature

Deepak Garg et al.

Summary: The study discussed a case of probable pulmonary mucormycosis in a COVID-19 patient, highlighting the severity of the disease and the importance of aggressive management for better outcomes. A systematic review revealed that diabetes mellitus was the most common risk factor, and the concurrent use of glucocorticoids may also increase the risk of mucormycosis.

MYCOPATHOLOGIA (2021)

添加到收藏夹

Article Infectious Diseases

A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India

A. Patel et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

添加到收藏夹

Letter Critical Care Medicine

Bronchoscopy in Patients with COVID-19 with Invasive Mechanical Ventilation: A Single-Center Experience

Alfons Torrego et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Pharmacokinetics and Pharmacodynamics of Posaconazole

Lu Chen et al.

DRUGS (2020)

添加到收藏夹

Article Infectious Diseases

Evaluation of MucorGenius® mucorales PCR assay for the diagnosis of pulmonary mucormycosis

Helene Guegan et al.

JOURNAL OF INFECTION (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Transforming a General Hospital to an Infectious Disease Hospital for COVID-19 Over 2 Weeks

Navin Pandey et al.

FRONTIERS IN PUBLIC HEALTH (2020)

添加到收藏夹

Article Microbiology

Isavuconazole Treatment in a Mixed Patient Cohort with Invasive Fungal Infections: Outcome, Tolerability and Clinical Implications of Isavuconazole Plasma Concentrations

Christoph Zurl et al.

JOURNAL OF FUNGI (2020)

添加到收藏夹

Review Infectious Diseases

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

Philipp Koehler et al.

LANCET INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis

Xun-Jie Cao et al.

BIOMED RESEARCH INTERNATIONAL (2020)

添加到收藏夹

Article Dermatology

Posaconazole salvage therapy: The Posifi study

Jestis Fortun et al.

MYCOSES (2019)

添加到收藏夹

Article Respiratory System

Factors affecting surgical resection and treatment outcomes in patients with pulmonary mucormycosis

Hayoung Choi et al.

JOURNAL OF THORACIC DISEASE (2019)

添加到收藏夹

Article Dermatology

Cut it out! Thoracic surgeon's approach to pulmonary mucormycosis and the role of surgical resection in survival

Ashrit Multani et al.

MYCOSES (2019)

添加到收藏夹

Article Microbiology

Comparison of Clinical Manifestation, Diagnosis, and Outcomes of Invasive Pulmonary Aspergillosis and Pulmonary Mucormycosis

Chun-Yu Lin et al.

MICROORGANISMS (2019)

添加到收藏夹

Review Infectious Diseases

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium

Oliver A. Cornely et al.

LANCET INFECTIOUS DISEASES (2019)

添加到收藏夹

Article Respiratory System

Clinical features of pulmonary mucormycosis in patients with different immune status

Min Peng et al.

JOURNAL OF THORACIC DISEASE (2019)

添加到收藏夹

Review Microbiology

Global Epidemiology of Mucormycosis

Hariprasath Prakash et al.

JOURNAL OF FUNGI (2019)

添加到收藏夹

Review Microbiology

Molecular Strategies to Diagnose Mucormycosis

Laurence Millon et al.

JOURNAL OF FUNGI (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

CT-guided Core-Needle Biopsy of the Lung Is Safe and More Effective than Fine-Needle Aspiration Biopsy in Patients with Hematologic Malignancies

Gaurav Watane et al.

RADIOLOGY-CARDIOTHORACIC IMAGING (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Pulmonary mucormycosis: serial morphologic changes on computed tomography correlate with clinical and pathologic findings

Bo Da Nam et al.

EUROPEAN RADIOLOGY (2018)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Pulmonary Mucormycosis: Radiologic Features at Presentation and Over Time

Mark M. Hammer et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2018)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Surgical Treatment of Multifocal Pulmonary Mucormycosis

Sara E. A. Mills et al.

ANNALS OF THORACIC SURGERY (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole

Matthew W. McCarthy et al.

CLINICAL PHARMACOKINETICS (2018)

添加到收藏夹

Review Infectious Diseases

Challenges in the diagnosis and treatment of mucormycosis

A. Skiada et al.

MEDICAL MYCOLOGY (2018)

添加到收藏夹

Article Respiratory System

Retrospective study of 25 cases of pulmonary mucormycosis in acute leukaemia

D. Caillot et al.

REVUE DES MALADIES RESPIRATOIRES (2018)

添加到收藏夹

Article Immunology

Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL

Elisabeth Wehrle-Wieland et al.

TRANSPLANT INFECTIOUS DISEASE (2018)

添加到收藏夹

Article Infectious Diseases

Diagnosing filamentous fungal infections in immunocompromised patients applying computed tomography-guided percutaneous lung biopsies: a 12-year experience

Cornelia Lass-Floerl et al.

INFECTION (2017)

添加到收藏夹

Article Infectious Diseases

Antifungal resistance in mucorales

E. Dannaoui

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)

添加到收藏夹

Article Microbiology

Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis

Wei Zhou et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2017)

添加到收藏夹

Article Respiratory System

Chronic pulmonary mucormycosis: an emerging fungal infection in diabetes mellitus

Nousheen Iqbal et al.

JOURNAL OF THORACIC DISEASE (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Diagnostic Performance of Contrast Enhanced Pulmonary Computed Tomography Angiography for the Detection of Angioinvasive Pulmonary Aspergillosis in Immunocompromised Patients

C. Henzler et al.

SCIENTIFIC REPORTS (2017)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

CT-Guided Percutaneous Lung Biopsies in Patients With Suspicion for Infection May Yield Clinically Useful Information

Brian M. Haas et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2017)

添加到收藏夹

Article Infectious Diseases

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease

Oliver A. Cornely et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Diagnostic value of (1 → 3)-β-D-glucan in bronchoalveolar lavage fluid for invasive fungal disease: A meta-analysis

Xin-yu Shi et al.

RESPIRATORY MEDICINE (2016)

添加到收藏夹

Article Microbiology

Multicenter Evaluation of MIC Distributions for Epidemiologic Cutoff Value Definition To Detect Amphotericin B, Posaconazole, and Itraconazole Resistance among the Most Clinically Relevant Species of Mucorales

A. Espinel-Ingroff et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

添加到收藏夹

Article Surgery

Challenges in the management of invasive pulmonary zygomycosis: the Alfred experience

Pankaj Saxena et al.

ANZ JOURNAL OF SURGERY (2015)

添加到收藏夹

Article Infectious Diseases

Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis

J. Jung et al.

CLINICAL MICROBIOLOGY AND INFECTION (2015)

添加到收藏夹

Article Infectious Diseases

Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis

F. Lanternier et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)

添加到收藏夹

Article Infectious Diseases

Bronchoscopy as an indicator of tracheobronchial fungal infection in non-neutropenic intensive-care unit patients

O. Yazicioglu Mocin et al.

CLINICAL MICROBIOLOGY AND INFECTION (2013)

添加到收藏夹

Article Infectious Diseases

Feasibility and outcome of CT-guided lung biopsy in patients with hematological diseases and suspected fungal pneumonia

Sanjeev Kumar Sharma et al.

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2013)

添加到收藏夹

Article Infectious Diseases

Risk Factors for Mortality in Patients with Invasive Mucormycosis

Hyo-Lim Hong et al.

INFECTION AND CHEMOTHERAPY (2013)

添加到收藏夹

Article Microbiology

In Vitro and In Vivo Activities of Posaconazole and Amphotericin B in a Murine Invasive Infection by Mucor circinelloides: Poor Efficacy of Posaconazole

Valentina Salas et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)

添加到收藏夹

Article Microbiology

Antifungal Susceptibility and Phylogeny of Opportunistic Members of the Order Mucorales

Roxana G. Vitale et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2012)

添加到收藏夹

Article Infectious Diseases

Zygomycosis: conventional laboratory diagnosis

C. Lass-Floerl

CLINICAL MICROBIOLOGY AND INFECTION (2009)

添加到收藏夹

Editorial Material Immunology

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses study group and European Organization for Research and Treatment of Cancer consensus criteria

Brahm H. Segal et al.

CLINICAL INFECTIOUS DISEASES (2008)

添加到收藏夹

Article Immunology

Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases

JAH van Burik et al.

CLINICAL INFECTIOUS DISEASES (2006)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Utility of computed tomography (CT) and of fine needle aspiration biopsy (FNAB) in early diagnosis of fungal pulmonary infections.: Study of infections from filamentous fungi in haematologically immunodeficient patients

G Carrafiello et al.

RADIOLOGIA MEDICA (2006)

添加到收藏夹

Article Medicine, General & Internal

Pulmonary mucormycosis: Two of a kind

Ritesh Agarwal et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2006)

添加到收藏夹

Article Immunology

Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer

G Chamilos et al.

CLINICAL INFECTIOUS DISEASES (2005)

添加到收藏夹

Article Medicine, General & Internal

Intradialytic administration of amphotericin B: Clinical observations on efficacy and safety

JE Wood et al.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2004)

添加到收藏夹

Article Pharmacology & Pharmacy

Cunninghamella bertholletiae infection in a bone marrow transplant patient:: Amphotericin lung penetration, MIC determinations, and review of the literature

KW Garey et al.

PHARMACOTHERAPY (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.